|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.972
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.942
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.925
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.920
|
Mouse |
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.920
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.862
|
|
|
|
regulation of viral genome replication
|
GO:0045069 |
48 |
0.822
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.821
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.766
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.725
|
Human |
|
|
defense response
|
GO:0006952 |
315 |
0.710
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.707
|
Mouse |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.690
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.673
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
66 |
0.661
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.608
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.608
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.557
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.523
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.497
|
Human |
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.478
|
|
|
|
entry into host
|
GO:0044409 |
25 |
0.469
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.466
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.464
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.450
|
Mouse |
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.418
|
Mouse |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.400
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.384
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.376
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.373
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
35 |
0.350
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.349
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.338
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.301
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.296
|
Mouse |
|
|
response to interferon alpha
|
GO:0035455 |
11 |
0.294
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.294
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.287
|
Mouse |
|
|
response to virus
|
GO:0009615 |
126 |
0.279
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
37 |
0.274
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.265
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.247
|
|
|
|
viral genome replication
|
GO:0019079 |
50 |
0.246
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.229
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.216
|
Human |
|
|
viral gene expression
|
GO:0019080 |
35 |
0.213
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.213
|
Human |
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
25 |
0.200
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.198
|
|
|
|
intracellular transport of virus
|
GO:0075733 |
14 |
0.196
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.192
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
4 |
0.192
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.191
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.187
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.185
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.158
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.153
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
25 |
0.149
|
|
|
|
regulation of viral entry into host cell
|
GO:0046596 |
17 |
0.142
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.138
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.132
|
|
|
|
viral transcription
|
GO:0019083 |
35 |
0.127
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.120
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.117
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.115
|
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
12 |
0.114
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.114
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.113
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.113
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.111
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.110
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.108
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.105
|
|
|
|
entry into host cell
|
GO:0030260 |
25 |
0.102
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.100
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.100
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.098
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.098
|
|
|
|
response to type i interferon
|
GO:0034340 |
14 |
0.097
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.096
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.095
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.093
|
|
|
|
multi organism localization
|
GO:1902579 |
14 |
0.091
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.090
|
Human |
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.087
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.084
|
|
|
|
regulation of protein export from nucleus
|
GO:0046825 |
15 |
0.083
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.082
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.079
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.079
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.078
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.075
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.075
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.074
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.071
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.070
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.070
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.068
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.067
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.065
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
23 |
0.063
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.060
|
|
|
|
viral entry into host cell
|
GO:0046718 |
24 |
0.059
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.059
|
Human |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.058
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.058
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.058
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.056
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.055
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.055
|
|
|
|
regulation of intracellular transport of viral material
|
GO:1901252 |
2 |
0.054
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.054
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.051
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.051
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.050
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.049
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.049
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.047
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.047
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.046
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
12 |
0.045
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.044
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.044
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.044
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.044
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.041
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.041
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.040
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.040
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.039
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.039
|
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.039
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.038
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.038
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.037
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.037
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.037
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.037
|
|
|
|
negative regulation of intracellular transport of viral material
|
GO:1901253 |
2 |
0.037
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.036
|
|
|
|
epinephrine secretion
|
GO:0048242 |
1 |
0.035
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.035
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.035
|
|
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
38 |
0.035
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.035
|
|
|
|
regulation of membrane depolarization
|
GO:0003254 |
19 |
0.034
|
|
|
|
interferon gamma production
|
GO:0032609 |
39 |
0.033
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.033
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.033
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.033
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.033
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.032
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.032
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.031
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.031
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.031
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.030
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.029
|
|
|
|
t cell proliferation
|
GO:0042098 |
45 |
0.029
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
11 |
0.029
|
|
|
|
regulation of protein deubiquitination
|
GO:0090085 |
4 |
0.029
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.028
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.028
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.028
|
|
|
|
entry into other organism involved in symbiotic interaction
|
GO:0051828 |
25 |
0.027
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.027
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.027
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.027
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.026
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
38 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.025
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.025
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.025
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.025
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
59 |
0.025
|
|
|
|
positive regulation of interleukin 13 production
|
GO:0032736 |
4 |
0.025
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.025
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.025
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.024
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.024
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.024
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.024
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.024
|
|
|
|
multi organism transport
|
GO:0044766 |
14 |
0.024
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.024
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.024
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.023
|
|
|
|
cytidine metabolic process
|
GO:0046087 |
7 |
0.023
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.023
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.023
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.022
|
|
|
|
response to interferon beta
|
GO:0035456 |
11 |
0.022
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.022
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.022
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.022
|
|
|
|
glycosylation
|
GO:0070085 |
71 |
0.022
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.022
|
|
|
|
nuclear export
|
GO:0051168 |
69 |
0.021
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.021
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.021
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.021
|
|
|
|
movement in host environment
|
GO:0052126 |
25 |
0.021
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.021
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.021
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
23 |
0.021
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.021
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.021
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.020
|
|
|
|
protein export from nucleus
|
GO:0006611 |
29 |
0.020
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.020
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
45 |
0.020
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.020
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
33 |
0.020
|
|
|
|
glucose metabolic process
|
GO:0006006 |
45 |
0.020
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.020
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.019
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.019
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.019
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.019
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.019
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.018
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.018
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
37 |
0.018
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
26 |
0.018
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.018
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.018
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.017
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.017
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.017
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.017
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
55 |
0.016
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.016
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.016
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.016
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.016
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
38 |
0.016
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.016
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.016
|
|
|
|
regulation of fas signaling pathway
|
GO:1902044 |
2 |
0.016
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.015
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.015
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
51 |
0.015
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.015
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.015
|
|
|
|
proteasomal ubiquitin independent protein catabolic process
|
GO:0010499 |
3 |
0.015
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.015
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.015
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.015
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.015
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.015
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.015
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.015
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.015
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
11 |
0.015
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.015
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.014
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.014
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.014
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.014
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.014
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.014
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.014
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.014
|
|
|
|
protein k63 linked ubiquitination
|
GO:0070534 |
31 |
0.013
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.013
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.013
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
67 |
0.013
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.013
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.013
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.013
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.013
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.013
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.013
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.013
|
|
|
|
negative regulation of interleukin 2 secretion
|
GO:1900041 |
2 |
0.013
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.013
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.013
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.012
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
46 |
0.012
|
|
|
|
rig i signaling pathway
|
GO:0039529 |
7 |
0.012
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.012
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.012
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
4 |
0.012
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.012
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
60 |
0.012
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.012
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.012
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.012
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
83 |
0.012
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.012
|
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
35 |
0.012
|
|
|
|
response to corticosteroid
|
GO:0031960 |
15 |
0.012
|
Human |
|
|
adenosine to inosine editing
|
GO:0006382 |
3 |
0.012
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.011
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.011
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.011
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.011
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.011
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.011
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.011
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
56 |
0.011
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.011
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.011
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.011
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.011
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.011
|
|
|
|
spindle elongation
|
GO:0051231 |
4 |
0.011
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.011
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.011
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.011
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
45 |
0.011
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.011
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.011
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.011
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
42 |
0.010
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.010
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.010
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.010
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.010
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.010
|
|
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.010
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.010
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.010
|
Human |
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.010
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.010
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
33 |
0.010
|
|